Differential intra-endothelial delivery of polymer nanocarriers targeted to distinct PECAM-1 epitopes.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Journal of Controlled Release

• Publication date

  2008-09-24

• Fields of study

  Medicine, Materials Science, Chemistry

• Identifiers
  DOI 10.1016/j.jconrel.2008.06.007PMID 18606202PMCID PMC2615664
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• RhoA activation and actin reorganization involved in endothelial CAM-mediated endocytosis of anti-PECAM carriers: critical role for tyrosine 686 in the cytoplasmic tail of PECAM-1.

  2008cited by this paper
• Endothelial targeting of semi-permeable polymer nanocarriers for enzyme therapies.

  2008cited by this paper
• The use of fluorescence microscopy to define polymer localisation to the late endocytic compartments in cells that are targets for drug delivery.

  2008cited by this paper
• Characterization of the intracellular dynamics of a non-degradative pathway accessed by polymer nanoparticles.

  2008cited by this paper
• Control of endothelial targeting and intracellular delivery of therapeutic enzymes by modulating the size and shape of ICAM-1-targeted carriers.

  2008cited by this paper
• Immunotargeting of catalase to lung endothelium via anti-angiotensin-converting enzyme antibodies attenuates ischemia-reperfusion injury of the lung in vivo.

  2007cited by this paper
• Endocytosis and Interaction of Poly (Amidoamine) Dendrimers with Caco-2 Cells

  2007cited by this paper
• Platelet-Endothelial Cell Adhesion Molecule-1-Directed Endothelial Targeting of Superoxide Dismutase Alleviates Oxidative Stress Caused by Either Extracellular or Intracellular Superoxide

  2007cited by this paper
• Targeted intracellular delivery of therapeutics: an overview.

  2007cited by this paper
• Factors modulating the delivery and effect of enzymatic cargo conjugated with antibodies targeted to the pulmonary endothelium.

  2007cited by this paper
• Optical Imaging of the Adoptive Transfer of Human Endothelial Cells in Mice Using Anti-Human CD31 Monoclonal Antibody

  2007cited by this paper
• “Alternative” endocytic mechanisms exploited by pathogens: New avenues for therapeutic delivery?

  2007cited by this paper
• Antibodies and peptides in cancer therapy.

  2006cited by this paper
• Endothelial Targeting of High-Affinity Multivalent Polymer Nanocarriers Directed to Intercellular Adhesion Molecule 1

  2006cited by this paper
• Recent approaches to intracellular delivery of drugs and DNA and organelle targeting.

  2006cited by this paper
• Advanced drug delivery systems that target the vascular endothelium.

  2006cited by this paper
• Endocytosis pathways in endothelium: how many?

  2006cited by this paper
• Cell adhesion molecules for targeted drug delivery.

  2006cited by this paper
• Loss of PECAM-1 Function Impairs Alveolarization*

  2006cited by this paper
• Recombinant polymers for cancer gene therapy: a minireview.

  2005cited by this paper
• Targeted delivery of therapeutic oligonucleotides to pulmonary circulation.

  2005cited by this paper
• ICAM-1 recycling in endothelial cells: a novel pathway for sustained intracellular delivery and prolonged effects of drugs.

  2005cited by this paper
• Targeting of antioxidant and anti-thrombotic drugs to endothelial cell adhesion molecules.

  2005cited by this paper
• Endothelial targeting of a recombinant construct fusing a PECAM-1 single-chain variable antibody fragment (scFv) with prourokinase facilitates prophylactic thrombolysis in the pulmonary vasculature.

  2005cited by this paper
• Biomedical aspects of targeted delivery of drugs to pulmonary endothelium

  2005cited by this paper
• Selective rat lung endothelial targeting with a new set of monoclonal antibodies to angiotensin I-converting enzyme.

  2005cited by this paper
• Subtractive proteomic mapping of the endothelial surface in lung and solid tumours for tissue-specific therapy

  2004cited by this paper
• Endothelial endocytic pathways: gates for vascular drug delivery.

  2004cited by this paper
• ICAM-directed vascular immunotargeting of antithrombotic agents to the endothelial luminal surface.

  2003cited by this paper
• Immunotargeting of catalase to the pulmonary endothelium alleviates oxidative stress and reduces acute lung transplantation injury

  2003cited by this paper
• Challenges in polymer therapeutics: state of the art and prospects of polymer drugs.

  2003cited by this paper
• PECAM-directed delivery of catalase to endothelium protects against pulmonary vascular oxidative stress.

  2003cited by this paper
• Slow intracellular trafficking of catalase nanoparticles targeted to ICAM-1 protects endothelial cells from oxidative stress.

  2003cited by this paper
• A novel endocytic pathway induced by clustering endothelial ICAM-1 or PECAM-1

  2003cited by this paper
• Size-dependent intracellular immunotargeting of therapeutic cargoes into endothelial cells.

  2002cited by this paper
• Evidence for the role of alveolar epithelial gp60 in active transalveolar albumin transport in the rat lung

  2001cited by this paper
• Cell‐selective intracellular delivery of a foreign enzyme to endothelium in vivo using vascular immunotargeting

  2001cited by this paper
• Targeting of superoxide dismutase and catalase to vascular endothelium.

  2001cited by this paper
• PECAM-1/CD31 trans-homophilic binding at the intercellular junctions is independent of its cytoplasmic domain; evidence for heterophilic interaction with integrin alphavbeta3 in Cis.

  2000cited by this paper
• Antibodies Against the First Ig-Like Domain of Human Platelet Endothelial Cell Adhesion Molecule-1 (PECAM-1) That Inhibit PECAM-1-Dependent Homophilic Adhesion Block In Vivo Neutrophil Recruitment1

  2000cited by this paper
• Streptavidin facilitates internalization and pulmonary targeting of an anti-endothelial cell antibody (platelet-endothelial cell adhesion molecule 1): a strategy for vascular immunotargeting of drugs.

  1999cited by this paper
• In vivo regulation of PECAM‐1 activity during acute endothelial dysfunction in the rat mesenteric microvasculature

  1998cited by this paper
• Residues on Both Faces of the First Immunoglobulin Fold Contribute to Homophilic Binding Sites of PECAM-1/CD31*

  1997cited by this paper
• Antibodies specific to the plasma membrane of rat lung microvascular endothelium.

  1997cited by this paper
• Endothelial cells internalize monoclonal antibody to angiotensin-converting enzyme.

  1996cited by this paper
• Localization of multiple functional domains on human PECAM-1 (CD31) by monoclonal antibody epitope mapping.

  1995cited by this paper
• IFN-gamma and TNF-alpha induce redistribution of PECAM-1 (CD31) on human endothelial cells.

  1995cited by this paper
• Interaction of mAb to angiotensin-converting enzyme (ACE) with antigen in vitro and in vivo: antibody targeting to the lung induces ACE antigenic modulation.

  1994cited by this paper
• Involvement of platelet-endothelial cell adhesion molecule-1 in neutrophil recruitment in vivo.

  1993cited by this paper
• gp60 is an albumin-binding glycoprotein expressed by continuous endothelium involved in albumin transcytosis.

  1992cited by this paper
• Endothelial transport of macromolecules: transcytosis and endocytosis. A look from cell biology.

  1991cited by this paper
• PECAM-1 (CD31) cloning and relation to adhesion molecules of the immunoglobulin gene superfamily.

  1990cited by this paper
• A human endothelial cell-restricted, externally disposed plasmalemmal protein enriched in intercellular junctions

  1989cited by this paper
• Permanent cell line expressing human factor VIII-related antigen established by hybridization.

  1983cited by this paper

• Equip your vehicle for the right terrain: Using features of local pathology to guide engineering of targeted drug delivery systems.

  2025cites this paper
• Anti – intercellular adhesion molecule-1(ICAM-1) nanoparticles for damaged endothelium to treat venous thromboembolism

  2024cites this paper
• Nanocarriers for targeted drug delivery in the vascular system: focus on endothelium

  2024cites this paper
• Isoform-specific vs. isoform-universal drug targeting: a new targeting paradigm illustrated by new anti-ICAM-1 antibodies

  2024influential citation
• Presence of ICAM-1 Isoforms in Human Cells Impacts the Selection of Antibodies for Nanocarrier Targeting

  2024cites this paper
• Fluorinated amphiphilic Poly(β-Amino ester) nanoparticle for highly efficient and specific delivery of nucleic acids to the Lung capillary endothelium

  2023cites this paper
• Lipid Nanoparticles for Nucleic Acid Delivery to Endothelial Cells

  2023cites this paper
• Targeted delivery of nutraceuticals derived from food for the treatment of obesity and its related complications.

  2023cites this paper
• Precise Nanodrug Delivery Systems with Cell-specific Targeting for ALI/ARDS Treatment.

  2023cites this paper
• Exploring state-of-the-art advances in targeted nanomedicines for managing acute and chronic inflammatory lung diseases.

  2022cites this paper
• Reactive Oxygen Species Scavenging Nanomedicine for the Treatment of Ischemic Heart Disease

  2022cites this paper
• Nucleic Acid Delivery to the Vascular Endothelium.

  2022cites this paper
• Genetically engineered cell membrane–coated nanoparticles for targeted delivery of dexamethasone to inflamed lungs

  2021cites this paper
• Intra-Organ Delivery of Nanotherapeutics for Organ Transplantation.

  2021cites this paper
• Modifying Cell Membranes with Anionic Polymer Amphiphiles Potentiates Intracellular Delivery of Cationic Peptides.

  2020cites this paper
• Targeting drug delivery in the vascular system: Focus on endothelium

  2020cites this paper
• Endothelial capture using antibodies and nanoparticles in human tissues: antigen identification and liver segment imaging.

  2019cites this paper
• Computational simulation of electromagnetic fields on human targets for magnetic targeting applications

  2019cites this paper
• Novel inhibitors of leukocyte transendothelial migration.

  2019cites this paper
• Flexible Nanoparticles Reach Sterically Obscured Endothelial Targets Inaccessible to Rigid Nanoparticles

  2018cites this paper
• Optimizing the Physical Properties of Vascular Targeted Carriers for Maximum Efficacy in Inflammatory Disease

  2018cites this paper
• Interaction of Poly(l-lysine)/Polysaccharide Complex Nanoparticles with Human Vascular Endothelial Cells

  2018cites this paper
• Nanoparticle targeting to the endothelium during normothermic machine perfusion of human kidneys

  2017cites this paper
• The Future of Nanoparticle-Directed Venous Therapy

  2017cites this paper
• The new frontiers of the targeted interventions in the pulmonary vasculature: precision and safety (2017 Grover Conference Series)

  2017cites this paper
• Investigation of Vesicular-Mediated Transport of Intercellular Adhesion Molecule-1-Targeted Carriers for Treatment of Lysosomal Storage Disorders

  2017cites this paper
• ICAM-1 targeting, intracellular trafficking, and functional activity of polymer nanocarriers coated with a fibrinogen-derived peptide for lysosomal enzyme replacement

  2017cites this paper
• Intracellular Drug Delivery: Mechanisms for Cell Entry.

  2016cites this paper
• Non-affinity factors modulating vascular targeting of nano- and microcarriers.

  2016cites this paper
• Molecular engineering of high affinity single-chain antibody fragment for endothelial targeting of proteins and nanocarriers in rodents and humans.

  2016cites this paper
• Endocytosis and the Endolysosomal Route in Drug Delivery

  2016cites this paper
• Evaluation of receptor‐ligand mechanisms of dual‐targeted particles to an inflamed endothelium

  2016cites this paper
• Size and targeting to PECAM vs ICAM control endothelial delivery, internalization and protective effect of multimolecular SOD conjugates.

  2016cites this paper
• How Carrier Size and Valency Modulate Receptor-Mediated Signaling: Understanding the Link between Binding and Endocytosis of ICAM-1-Targeted Carriers.

  2016cites this paper
• Influence of PECAM‐1 ligand interactions on PECAM‐1‐dependent cell motility and filopodia extension

  2016influential citation
• Collaborative Enhancement of Endothelial Targeting of Nanocarriers by Modulating Platelet-Endothelial Cell Adhesion Molecule-1/CD31 Epitope Engagement.

  2015cites this paper
• Endothelial nanomedicine for the treatment of pulmonary disease

  2015cites this paper
• Targeting, Endocytosis, and Lysosomal Delivery of Active Enzymes to Model Human Neurons by ICAM-1-Targeted Nanocarriers

  2015cites this paper
• PECAM-1 isoforms, eNOS and endoglin axis in regulation of angiogenesis.

  2015cites this paper
• Flow shear stress differentially regulates endothelial uptake of nanocarriers targeted to distinct epitopes of PECAM-1.

  2015cites this paper
• Targeted endothelial nanomedicine for common acute pathological conditions.

  2015influential citation
• Understanding and exploiting nanoparticles' intimacy with the blood vessel and blood.

  2015cites this paper
• Promising approaches to circumvent the blood-brain barrier: progress, pitfalls and clinical prospects in brain cancer.

  2015cites this paper
• Vascular Targeting of Nanocarriers: Perplexing Aspects of the Seemingly Straightforward Paradigm

  2014influential citation
• Desarrollo in vitro de nuevas terapias dirigidas con nanopartículas para el tratamiento del cáncer de tiroides.

  2014influential citation
• Lysosomes and Nanotherapeutics: Diseases, Treatments, and Side Effects

  2014cites this paper
• Combination-targeting to multiple endothelial cell adhesion molecules modulates binding, endocytosis, and in vivo biodistribution of drug nanocarriers and their therapeutic cargoes.

  2014cites this paper
• Receptor-targeted drug delivery: current perspective and challenges.

  2014cites this paper
• Heart-targeted nanoscale drug delivery systems.

  2014cites this paper
• Nanocarriers for vascular delivery of anti-inflammatory agents.

  2014cites this paper
• A programmable sensor to probe the internalization of proteins and nanoparticles in live cells.

  2013cites this paper
• Comparative binding, endocytosis, and biodistribution of antibodies and antibody-coated carriers for targeted delivery of lysosomal enzymes to ICAM-1 versus transferrin receptor

  2013cites this paper
• APPLICATIONS OF ANTIOXIDANT AND ANTI-INFLAMMATORY POLYMERS TO INHIBIT INJURY AND DISEASE

  2013cites this paper
• Targeted Drug Delivery to Endothelial Adhesion Molecules

  2013influential citation
• Biological functionalization of drug delivery carriers to bypass size restrictions of receptor-mediated endocytosis independently from receptor targeting.

  2013cites this paper
• Targeting Dendritic Cells: The Role of Specific Receptors in the Internalization of Polymer Capsules

  2013cites this paper
• In vivo performance of polymer nanocarriers dually-targeted to epitopes of the same or different receptors.

  2013cites this paper
• Suppressing iron oxide nanoparticle toxicity by vascular targeted antioxidant polymer nanoparticles.

  2013cites this paper
• Nanotechnology-Guided Imaging of Retinal Vascular Disease

  2012cites this paper
• Actions of the Kunitz-type serine protease inhibitor Amblyomin-X on VEGF-A-induced angiogenesis.

  2012cites this paper
• A Fibrinogen-Derived Peptide Provides Intercellular Adhesion Molecule-1-Specific Targeting and Intraendothelial Transport of Polymer Nanocarriers in Human Cell Cultures and Mice

  2012influential citation
• Challenges in design and characterization of ligand-targeted drug delivery systems.

  2012cites this paper
• Collaborative Enhancement of Antibody Binding to Distinct PECAM-1 Epitopes Modulates Endothelial Targeting

  2012cites this paper
• Strategies for delivery of therapeutics into the central nervous system for treatment of lysosomal storage disorders

  2012cites this paper
• Cardiac Protection with Targeted Drug Delivery to Ischemic-Reperfused Myocardium

  2012cites this paper
• Nanotechnology in interventional cardiology.

  2012cites this paper
• Nitric oxide modulates lipopolysaccharide‐induced endothelial platelet endothelial cell adhesion molecule expression via interleukin‐10

  2011cites this paper
• Targeting delivery of drugs in the vascular system.

  2011cites this paper
• Endothelial targeting of antibody-decorated polymeric filomicelles.

  2011cites this paper
• In vivo hydroquinone exposure alters circulating neutrophil activities and impairs LPS-induced lung inflammation in mice.

  2011cites this paper
• Nanotechnology Approaches to Contrast Enhancement in Optical Imaging and Disease‐Targeted Therapy

  2011cites this paper
• Effects of chlorogenic acid on neutrophil locomotion functions in response to inflammatory stimulus.

  2011cites this paper
• Targeted modulation of reactive oxygen species in the vascular endothelium.

  2011cites this paper
• Targeted Delivery of Protein Drugs by Nanocarriers

  2010cites this paper
• SHP-2 phosphatase activity is required for PECAM-1-dependent cell motility.

  2010cites this paper
• Targeted drug delivery to ischemic heart with use of nanoparticulate carriers

  2010cites this paper
• Design Parameters Modulating Intracellular Drug Delivery: Anchoring to Specific Cellular Epitopes, Carrier Geometry, and Use of Auxiliary Pharmacological Agents

  2010cites this paper
• Protein delivery: from conventional drug delivery carriers to polymeric nanoreactors

  2010cites this paper
• New biotechnological and nanomedicine strategies for treatment of lysosomal storage disorders.

  2010cites this paper
• Imaging of molecular signatures of specific structures, functions,and pathological alterations in the lung tissue.Chair's Summary.

  2009cites this paper
• Polymeric carriers: role of geometry in drug delivery

  2008cites this paper